Prevail News

YES

NO

Ineffective: Any benefits are too small to be worth the drawbacks

Unproven but promising: Too early to tell

Valuable but imperfect: Some healthy adults should consider it, but there are major drawbacks

Harmful/scandalous: Clear serious drawbacks that last beyond cessation of treatment

YES

YES

Before January 1, 2027

Before July 1, 2026

Before April 1, 2026

Before March 1, 2026

Before February 15, 2026

NO

Taylor Rehmet

Leigh Wambsganss

YES

[Consumer Privacy] A.T. v. OpenAI LP (N.D. Cal. 2023)

[Copyright] Authors Guild v. OpenAI Inc. (S.D.N.Y. 2023)

[Copyright] Sancton v. OpenAI Inc. (S.D.N.Y. 2023)

[Copyright] Chabon v. OpenAI, Inc. (N.D. Cal. 2023)

[Copyright] Silverman v. OpenAI, Inc. (N.D. Cal. 2023)

[Libel] Walters v. OpenAI, L.L.C. (Ga. Super. Ct. 2023)

NO

NO